A peptide motif consisting of glycine, alanine, and valine is required for the fibrillization and cytotoxicity of human α-synuclein

被引:147
作者
Du, HN
Tang, L
Luo, XY
Li, HT
Hu, J
Zhou, JW
Hu, HY [1 ]
机构
[1] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Key Lab Proteom, Shanghai 200031, Peoples R China
[2] Acad Sinica, Shanghai Inst Nucl Res, Shanghai 201800, Peoples R China
[3] Shanghai Jiao Tong Univ, Bio X Res Ctr, Shanghai 200030, Peoples R China
关键词
D O I
10.1021/bi034028+
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Amyloid-like aggregation or fibrillization of alpha-synuclein (alpha-Syn) and the filamentous deposits in Lewy bodies are believed to be closely associated with several fatal neurodegenerative disorders, including Parkinson's disease and Alzheimer's disease. Here, we report the importance of a nine-residue peptide Motif, (66)VGGAVVTGV(74), in the fibrillization and cytotoxicity of human alpha-Syn. Mutagenesis combined with thioflavin T fluorescence detection, atomic force microscopic imaging, and cytotoxicity assays reveal that deletion of this sequence completely eliminates alpha-Syn fibrillization and cell toxicity. However, deletion of the (71)VTGV(74) sequence decreases the fibrillization rate while the cytotoxicity remains unchanged. Incorporation of charged residues within this region slows aggregation and even impedes filament formation. In addition, substitution of Gly68 with Ala or C-terminal truncations of alpha-Syn accelerate the fibrillization processes. Circular dichroism studies suggest that beta-sheet formation is often concomitant with filament formation. Thus, this segment, namely, the GAV motif, is responsible for aggregation or fibrillization of alpha-Syn and perhaps other amyloidogenic proteins. The oligomers formed during fibrillogenesis might be associated with the cytotoxicities of various alpha-Syn species. This finding may provide further insight into the understanding of the molecular mechanism underlying the fibrillogenesis implicated in neurodegeneration as well as aid in drug design and development of transgenic models.
引用
收藏
页码:8870 / 8878
页数:9
相关论文
共 45 条
[1]   Mechanism of inactivation on prion conversion of the Saccharomyces cerevisiae Ure2 protein [J].
Baxa, U ;
Speransky, V ;
Steven, AC ;
Wickner, RB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (08) :5253-5260
[2]   Parkinson's disease-associated α-sylnuclein is more fibrillogenic than β- and γ-synuclein and cannot cross-seed its homologs [J].
Biere, AL ;
Wood, SJ ;
Wypych, J ;
Steavenson, S ;
Jiang, YJ ;
Anafi, D ;
Jacobsen, FW ;
Jarosinski, MA ;
Wu, GM ;
Louis, JC ;
Martin, F ;
Narhi, LO ;
Citron, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (44) :34574-34579
[3]   Identification of the region of non-Aβ component (NAC) of Alzheimer's disease amyloid responsible for its aggregation and toxicity [J].
Bodles, AM ;
Guthrie, DJS ;
Greer, B ;
Irvine, GB .
JOURNAL OF NEUROCHEMISTRY, 2001, 78 (02) :384-395
[4]   Role of microglia and host prion protein in neurotoxicity of a prion protein fragment [J].
Brown, DR ;
Schmidt, B ;
Kretzschmar, HA .
NATURE, 1996, 380 (6572) :345-347
[5]   Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases [J].
Bucciantini, M ;
Giannoni, E ;
Chiti, F ;
Baroni, F ;
Formigli, L ;
Zurdo, JS ;
Taddei, N ;
Ramponi, G ;
Dobson, CM ;
Stefani, M .
NATURE, 2002, 416 (6880) :507-511
[6]   The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease [J].
Clayton, DF ;
George, JM .
TRENDS IN NEUROSCIENCES, 1998, 21 (06) :249-254
[7]   Fibrils formed in vitro from α-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid [J].
Conway, KA ;
Harper, JD ;
Lansbury, PT .
BIOCHEMISTRY, 2000, 39 (10) :2552-2563
[8]   Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy [J].
Conway, KA ;
Lee, SJ ;
Rochet, JC ;
Ding, TT ;
Williamson, RE ;
Lansbury, PT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (02) :571-576
[9]   α-Synuclein and the Lewy body disorders [J].
Dickson, DW .
CURRENT OPINION IN NEUROLOGY, 2001, 14 (04) :423-432
[10]   Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of α-synuclein protein implicated in Parkinson's disease [J].
El-Agnaf, OMA ;
Jakes, R ;
Curran, MD ;
Wallace, A .
FEBS LETTERS, 1998, 440 (1-2) :67-70